Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral Lacosamide (SPM 927) in Patients With Partial Seizures

NCT00515619 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00515619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00515619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral Lacosamide (SPM 927) in Patients With Partial Seizures
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
August 31, 2010
Enrollment
376 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy